Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus

P. Titorenkov (Sofia, Bulgaria), M. Encheva (Sofia, Bulgaria), A. Chervenivanova (Sofia, Bulgaria), P. Chipev (Sofia, Bulgaria), D. Marinova (Sofia, Bulgaria), K. Kostov (Sofia, Bulgaria)

Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Session: COPD and extrapulmonary comorbidities
Session type: Thematic Poster
Number: 4025
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Titorenkov (Sofia, Bulgaria), M. Encheva (Sofia, Bulgaria), A. Chervenivanova (Sofia, Bulgaria), P. Chipev (Sofia, Bulgaria), D. Marinova (Sofia, Bulgaria), K. Kostov (Sofia, Bulgaria). Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus. 4025

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A study of the comorbidity of COPD and type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

Comparison of COPD patients with and without diabetes mellitus
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020


COPD prevalence and severity is associated to type 2 diabetes mellitus complications and lack of glycometabolic control
Source: Annual Congress 2008 - COPD and comorbidities
Year: 2008

Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2?
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009

Impact of diabetes in patients with COPD
Source: Virtual Congress 2020 – COPD and the impact of comorbidities
Year: 2020


Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012


Safety profile of COPD medications in COPD patients with concomitant diabetes mellitus
Source: International Congress 2017 – COPD management
Year: 2017

Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004

Relative risk of type 2 diabetes mellitus complications is increased in non effectively treated OSA patients
Source: Eur Respir J 2005; 26: Suppl. 49, 39s
Year: 2005

Approach to the diagnostics of early carbon metabolism disorders and diabetes mellitus 2 type in COPD patients
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013

Risk of development of diabetes mellitus in patients with bronchial asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 323s
Year: 2006

Death rate of COPD patients and combination with type 2 diabetes
Source: Eur Respir J 2007; 30: Suppl. 51, 79s
Year: 2007

Study of the connection between COPD, bronchial asthma and diabetes mellitus types 1 and 2
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009

Metformin predispose acute exacerbations of COPD patients with insulin-dependent diabetes mellitus>
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018

Effect of roflumilast (ROF) on glucose levels in patients with COPD and diabetes mellitus type 2 (DM2)
Source: Annual Congress 2010 - COPD: management
Year: 2010

Development of diabetes mellitus in patients with bronchial asthma
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD II
Year: 2008

Clinical features of pulmonary tuberculosis in patients with diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012


Study of PFT‘s in patients with type 2 diabetes mellitus and diabetic neuropathy and microangiopathy
Source: Annual Congress 2007 - Lung function and therapy in obstructive lung diseases
Year: 2007


The conjunctival microcirculation disturbances at COPD patients in combination with diabetes mellitus type 2 and their correction by gliclazide
Source: Eur Respir J 2004; 24: Suppl. 48, 61s
Year: 2004

Study of pulmonary function in type2 diabetes mellitus and its changes with change in duration and glycemic control
Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights
Year: 2012